Bulletin
Investor Alert

Evolent Health Inc. Cl A

NYS: EVH

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Aug 7, 2020, 4:58 p.m.

EVH
/zigman2/quotes/207127728/composite

$

13.06

Change

0.00 0.00%

Volume

Volume 46,629

Quotes are delayed by 20 min

/zigman2/quotes/207127728/composite

Previous close

$ 13.35

$ 13.06

Change

-0.29 -2.17%

Day low

Day high

$12.60

$13.33

Open

52 week low

52 week high

$3.50

$13.36

Open

Annual Financials for Evolent Health Inc. Cl A

Fiscal year is January-December. All values USD millions. 20152016201720182019 5-year trend
Sales/Revenue 96.88M254.19M434.95M627.06M846.38M
Cost of Goods Sold (COGS) incl. D&A 64.56M172.3M296.22M372.34M710.75M
COGS excluding D&A 57.4M155.08M263.85M327.83M644.11M
Depreciation & Amortization Expense 7.17M17.22M32.37M44.52M66.64M
Depreciation 1.2M2.6M9.2M17.3M23.3M
Amortization of Intangibles 5.97M14.62M23.17M27.22M37.61M
Gross Income 32.31M81.89M138.73M254.72M135.64M
20152016201720182019 5-year trend
SG&A Expense 75.29M157.5M202.54M231.02M238.65M
Research & Development 5.8M11.1M17.2M18.2M19.8M
Other SG&A 69.49M146.4M185.34M212.82M218.85M
Other Operating Expense -91,000(7.37M)--
Unusual Expense (414.13M)161.71M16.4M71.19M213.2M
EBIT after Unusual Expense 371.16M(237.42M)(72.84M)(47.48M)(316.21M)
Non Operating Income/Expense -4,000171,000109,0009.11M
Non-Operating Interest Income 293,000723,0001.66M3.44M3.99M
Equity in Affiliates (Pretax) (28.17M)(841,000)(1.76M)(4.74M)(9.47M)
Interest Expense --3.64M5.48M14.53M
Gross Interest Expense --3.64M5.48M14.53M
Interest Capitalized -----
Pretax Income 343.29M(237.53M)(76.4M)(54.15M)(327.12M)
Income Tax 23.48M(10.76M)(6.64M)40,000(21.54M)
Income Tax - Current Domestic 15,00091,000(6.74M)16.91M10.44M
Income Tax - Current Foreign ---251,000399,000
Income Tax - Deferred Domestic 23.46M(10.85M)100,000(17.07M)(32.38M)
Income Tax - Deferred Foreign ---(49,000)6,000
Income Tax Credits -----
Equity in Affiliates -----
Other After Tax Income (Expense) -----
Consolidated Net Income 319.81M(226.78M)(69.77M)(54.19M)(305.58M)
Minority Interest Expense (12.68M)(67.04M)(9.1M)(1.53M)(3.61M)
Net Income 332.49M(159.74M)(60.67M)(52.66M)(301.97M)
Extraordinaries & Discontinued Operations -----
Extra Items & Gain/Loss Sale Of Assets -----
Cumulative Effect - Accounting Chg -----
Discontinued Operations -----
Net Income After Extraordinaries 332.49M(159.74M)(60.67M)(52.66M)(301.97M)
Preferred Dividends 2.18M----
Net Income Available to Common 330.31M(159.74M)(60.67M)(52.66M)(301.97M)
EPS (Basic) 13.14(3.55)(0.94)(0.68)(3.67)
Basic Shares Outstanding 25.13M45.03M64.35M77.34M82.36M
EPS (Diluted) 6.93(3.55)(0.94)(0.68)(3.67)
Diluted Shares Outstanding 46.14M45.03M64.35M77.34M82.36M
EBITDA (35.81M)(58.48M)(24.07M)68.22M(36.37M)
Trending Tickers
  • /quotes/zigman/17636479/composite VUZI+15.60%
  • /quotes/zigman/237947/composite JCP-5.83%
  • /quotes/zigman/59392505/composite NUGT-2.93%
  • /quotes/zigman/59386294/composite JNUG-5.94%
  • /quotes/zigman/65801738/composite TLT+1.11%
X
Powered by StockTwits
Link to MarketWatch's Slice.